Back
Monopar Therapeutics Stock Predictions

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
41
MNPR
Monopar Therapeutics
Last Price:
$33.10
Seasonality Move:
115.3%
7 Day Trial
ALL ACCESS PASS
$
7
Monopar Therapeutics Stock Forecast
-
Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 226.9% based on the past 5 years of stock performance.
-
Monopar Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
-
Is Monopar Therapeutics Stock Undervalued?The current Monopar Therapeutics [MNPR] share price is $35.71. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Monopar Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Monopar Therapeutics has on average historically risen by 226.9% based on the past 5 years of stock performance.
Monopar Therapeutics Stock Rating
Sell
41
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics overpriced?
-
Monopar Therapeutics has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
Monopar Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
monopartx.com
52-Week Data
52-Week High:
54.30
52-Week Low:
2.15
Prediction Charts
Market Cap:
220.3M
Price in USD:
35.71
Volume:
17.5K
Beta:
1.23
Technical Analysis
SMA50:
38.15
SMA100:
37.71
SMA200:
33.38
52-Wk Change:
1406.75%
Stock Predictions
-
Is Monopar Therapeutics stock public?Yes, Monopar Therapeutics is a publicly traded company.
-
What is the Monopar Therapeutics stock quote today?The Monopar Therapeutics stock price is 35.71 USD today.
-
How to buy Monopar Therapeutics stock online?You can buy Monopar Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jul-30 | 44.34 | 42.66 | 44.34 | 41.67 |
Jul-31 | 42.65 | 41.18 | 42.65 | 40.71 |
Aug-1 | 40.01 | 40.69 | 41.60 | 39.61 |
Aug-4 | 40.54 | 41.75 | 42.21 | 39.92 |
Aug-5 | 42.50 | 40.45 | 42.50 | 39.24 |
Aug-6 | 41.70 | 40.65 | 41.70 | 39.50 |
Aug-7 | 41.70 | 40.10 | 41.70 | 39.50 |
Aug-8 | 41.00 | 34.65 | 41.49 | 34.65 |
Aug-11 | 35.80 | 31.34 | 35.80 | 30.51 |
Aug-12 | 30.90 | 35.90 | 35.90 | 30.90 |
Aug-13 | 35.13 | 33.51 | 36.06 | 32.01 |
Aug-14 | 32.57 | 35.86 | 36.51 | 32.57 |
Aug-15 | 36.14 | 35.71 | 36.23 | 34.03 |
Aug-18 | 35.69 | 34.26 | 37.56 | 34.15 |
Monopar Therapeutics Earnings
Monopar Therapeutics Earnings Report: Per Share Monopar Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Monopar Therapeutics Forecast Revenue Growth
Monopar Therapeutics Stock Analysis: Historical quarterly revenues per share for Monopar Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.69 per share, a decrease next quarter of $0.26 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.70 per share.
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.